These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26444094)

  • 1. Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?
    Yarnall AJ; Lawson RA; Duncan GW; Breen DP; Khoo TK; Brooks D; Barker RA; Taylor JP; Burn DJ
    J Parkinsons Dis; 2015; 5(4):743-7. PubMed ID: 26444094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study.
    Sumbul-Sekerci B; Bilgic B; Pasin O; Emre M; Hanagasi HA
    Dement Geriatr Cogn Disord; 2022; 51(5):386-395. PubMed ID: 36273437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.
    Sheu JJ; Tsai MT; Erickson SR; Wu CH
    Pharmacotherapy; 2019 Aug; 39(8):798-808. PubMed ID: 31251824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
    J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic Medication Burden in Parkinson's Disease Outpatients.
    Nawaz H; Sargent L; Quilon H; Cloud LJ; Testa CM; Snider JD; Lageman SK; Baron MS; Berman BD; Zimmerman K; Price ET; Mukhopadhyay ND; Barrett MJ
    J Parkinsons Dis; 2022; 12(2):599-606. PubMed ID: 34806617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of anticholinergic load in Australian community-dwelling older people: a longitudinal analysis.
    Mate KE; Barnett M; Kerr KP; Pond CD; Magin PJ
    Fam Pract; 2020 Jul; 37(3):314-320. PubMed ID: 31784733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.
    Chatterjee S; Mehta S; Sherer JT; Aparasu RR
    Drugs Aging; 2010 Dec; 27(12):987-97. PubMed ID: 21087068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Drugs on Mild Cognitive Impairment in Parkinson's Disease: Evidence from the PACOS Study.
    Cicero CE; Monastero R; Terravecchia C; Donzuso G; Luca A; Baschi R; Caccamo M; Mostile G; Giuliano L; Zappia M; Nicoletti A
    Curr Neuropharmacol; 2022; 20(5):998-1003. PubMed ID: 34951389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
    Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
    Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergic therapy and dementia in patients with Parkinson's disease.
    Pondal M; Del Ser T; Bermejo F
    J Neurol; 1996 Jul; 243(7):543-6. PubMed ID: 8836945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.
    Lee EK; Lee YJ
    Int J Clin Pharm; 2013 Oct; 35(5):711-8. PubMed ID: 23708883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic burden in Parkinson's disease inpatients.
    Lertxundi U; Isla A; Solinis MA; Domingo-Echaburu S; Hernandez R; Peral-Aguirregoitia J; Medrano J
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1271-7. PubMed ID: 26254777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of multiple low-level anticholinergic medications on anticholinergic load of community-dwelling elderly with and without dementia.
    Mate KE; Kerr KP; Pond D; Williams EJ; Marley J; Disler P; Brodaty H; Magin PJ
    Drugs Aging; 2015 Feb; 32(2):159-67. PubMed ID: 25566958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.
    Ehrt U; Broich K; Larsen JP; Ballard C; Aarsland D
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):160-5. PubMed ID: 19770163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
    Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
    Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
    Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
    JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of anticholinergic drugs withdrawal on motor function in patients with Parkinson's disease.
    Saeedi Y; Ghadimi M; Rohani M; Emamikhah M; Shahidi G; Moghaddasi M; Habibi SAH
    Clin Neurol Neurosurg; 2021 Mar; 202():106480. PubMed ID: 33503509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergics and clinical outcomes amongst people with pre-existing dementia: A systematic review.
    Wang K; Alan J; Page AT; Dimopoulos E; Etherton-Beer C
    Maturitas; 2021 Sep; 151():1-14. PubMed ID: 34446273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.